Pulse Biosciences (PLSE) Shares Outstanding (Weighted Average) (2015 - 2025)

Pulse Biosciences' Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $67.4 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 2148.78% year-over-year to $67.4 million; the TTM figure through Dec 2025 stood at $67.4 million (up 2148.78% YoY), while the FY2025 annual figure was $67.4 million, up 2148.78% from the prior year.
• Shares Outstanding (Weighted Average) was $67.4 million for Q4 2025 at Pulse Biosciences, roughly flat from $67.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $67.4 million in Q4 2025 to a low of $3.0 million in Q4 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $40.2 million across 5 years, with a median of $46.1 million in 2023.
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Weighted Average) jumped 4515.55% in 2021, then sank 93.97% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.6 million in 2021, then tumbled by 75.33% to $7.3 million in 2022, then soared by 580.97% to $49.7 million in 2023, then tumbled by 93.97% to $3.0 million in 2024, then surged by 2148.78% to $67.4 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $67.4 million (Q4 2025), $67.3 million (Q3 2025), and $67.2 million (Q2 2025), per Business Quant data.